Discover 1,106 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
With many research studies being conducted across the state, Indiana provides opportunities for both healthy volunteers interested in paid studies and individuals with specific health needs. Research centers in Indianapolis, Fort Wayne, and South Bend are actively recruiting participants, granting access to advanced treatments and innovative healthcare.
Filter
1
Filter results
Results: 1,106
Active & Responsive
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
for
Aortic Stenosis Treated With TAVI, Aortic Diseases
Location: New York NY, Cleveland OH, Detroit MI, Indianappolis IN,
Sponsor: EnCompass Technologies, Inc.
Sex: All
Age: 50+
Code: NCT06689839
Recruiting
Active & Responsive
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
for
Left-sided Colorectal Cancer
Location: Savannah GA, Warner Robins GA, Indianapolis IN,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07702032
Phase3, Recruiting
Active & Responsive
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: New York NY, Philadelphia PA, Coral Gables FL,
Sponsor: Ankyra Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07027514
Phase1, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: North Haven CT, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Overground Virtual Reality (VR) Gait Rehabilitation for Stroke
for
Stroke
Location: Indianapolis IN
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT07676578
Recruiting
Active & Responsive
Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer
for
Small Cell Lung Cancer ( SCLC ),
Location: Indianapolis IN
Sponsor: Misty Shields
Sex: All
Age: 18+
Code: NCT07153055
Phase1, Phase2, Recruiting
Active & Responsive
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Location: Hauppauge NY, Cherry Hill NJ, Bethlehem PA,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07440225
Phase2, Phase3, Recruiting
Active & Responsive
The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV
for
HIV, Depression in Adults, Insulin Resistance,
Location: Indianapolis IN
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT07226128
Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Boston MA, New York NY, Durham NC, Boca Raton FL,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase2, Recruiting
Active & Responsive
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Boston MA, North Haven CT, New York NY, Baltimore MD,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07100990
Phase3, Recruiting
Active & Responsive
Clinical Course Of Disease In Participants With FA-CM
for
Friedreich Ataxia, Cardiomyopathy
Location: Boston MA, Montreal, Tampa FL, Cincinnati OH,
Sponsor: Lexeo Therapeutics
Sex: All
Age: 6+
Code: NCT06865482
Recruiting
Active & Responsive
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
for
Atherosclerotic Cardiovascular Disease (ASCVD)
Location: Summit NJ, Bowie MD, Ft. Washington MD, Falls Church VA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06813911
Phase3, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase3, Recruiting
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,